| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 3,988,000 | 3,964,800 | 3,713,000 | 3,642,200 | | Cost of Revenue | 1,751,800 | 1,725,000 | 1,613,200 | 1,599,000 | | | Gross Profit | 2,236,200 | 2,239,800 | 2,099,800 | 2,043,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,415,400 | 1,395,500 | 1,376,100 | 1,246,300 | | Non Recurring | (77,300) | 77,300 |
-
| 39,700 | | Others |
-
|
-
|
-
| 18,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 898,100 | 767,000 | 723,700 | 739,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (129,700) |
-
|
-
| 10,000 | | Earnings Before Interest And Taxes | 768,400 | 767,000 | 723,700 | 685,600 | | Interest Expense | 22,900 | 25,400 | 33,700 | 45,000 | | Income Before Tax | 745,500 | 741,600 | 690,000 | 640,600 | | Income Tax Expense | 245,600 | 247,800 | 223,500 | 225,700 | | Minority Interest |
-
|
-
|
-
| (67,100) | | | | Net Income From Continuing Ops | 499,900 | 493,800 | 466,500 | 414,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 499,900 | 493,800 | 466,500 | 414,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $499,900 | $493,800 | $466,500 | $414,900 |
|
2.05% Nasdaq 
Income Statement
